Results

301 - 310 of 321 results for ‘guidelines’.

  • COVID-19

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/communicable-disease-control-manual/covid-19

    Chapter last reviewed and updated in  October 2024.  Changes were made to the Laboratory testing guidelines. A description of changes can be found at  Updates to the Communicable Disease Control Manual (external link) Epidemiology Expand all Global Epidemiology Global Epidemiology Coronavirus disease 2019 (COVID‑19) is caused by the SARS-CoV-2 virus, which infects the respiratory tract and is transmitted human to human primarily through respiratory droplets and aerosols. Documented transmission has also occurred through direct contact and rarely fomites (objects or materials ...

  • Data dictionaries

    http://tewhatuora.govt.nz/for-health-professionals/data-and-statistics/nz-health-statistics/data-references/data-dictionaries

    ... each year to be used in international comparisons of mortality statistics. The Mortality Collection classifies the underlying cause of death for all deaths registered in New Zealand, including all registered fetal deaths (stillbirths), using the ICD-10-AM 8th Edition and the WHO Rules and Guidelines for Mortality Coding. Fetal and infant data is a subset of the mortality collection. Extra variables such as gestation and birth weight are collected. Mortality Collection data dictionary v1.8 [DOCX, 431 KB] Mortality Collection data dictionary v1.7 [PDF, 1.3 MB] Mortality Collection data dict ...

  • New Zealand Coding Authority coding queries

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/data-and-statistics/nz-health-statistics/classification/new-zealand-coding-authority/coding-queries

    ... on a referral letter/form alone is insufficient for a code assignment. The condition must be documented within the current episode of admitted patient care. Refer to ACS 0003 Supplementary codes for chronic conditions , ACS 0010  Clinical documentation and general abstraction guidelines and the IHACPA Coding Rules: Q3008 Assignment of U codes from patient documentation TN1601 Twelfth Edition FAQ: Referrals requesting admission ACS 1521 Conditions and injuries in pregnancy – non-obstetric conditions complicating pregnancy ACS 1521 Conditions and injuries in pregnancy – non ...

  • 18. Poliomyelitis

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/18-poliomyelitis

    ... ). There is no evidence for the need for routine boosters, but they are recommended to reduce any possible risk from waning immunity in situations of increased risk of exposure. 18.6. Contraindications and precautions See also   section 2.1.3  for pre-vaccination screening guidelines and   section 2.1.4   for general contraindications for all vaccines. Expand all 18.6.1. Contraindications 18.6.1. Contraindications IPV‑containing vaccines are contraindicated if there is a history of an anaphylactic reaction to a previous dose or to any of the vaccine comp ...

  • Mpox

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/communicable-disease-control-manual/mpox

    ... response objectives. For an overview of all updates made to the Communicable Disease Control Manual, refer to Updates to the Communicable Disease Control Manual – Health New Zealand | Te Whatu Ora . 2024 2024 November Updates to Contact management  Updates to Laboratory testing guidelines August Updates to Management of Case For an overview of all updates made to the Communicable Disease Control Manual, refer to  Updates to the Communicable Disease Control Manual – Health New Zealand | Te Whatu Ora . Epidemiology Expand all Global epidemiology Global epidemiology Mpox is ...

  • 7. Haemophilus influenzae type b (Hib) disease

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/7-haemophilus-inuenzae-type-b-hib-disease

    ... for pregnant or breastfeeding women. However, for women with asplenia see the ‘ Recommendations for Hib vaccine for older children and adults with asplenia ’ in   section 7.5.2 . 7.6. Contraindications and precautions See also   section 2.1.3   for pre-vaccination screening guidelines and   section 2.1.4   for general vaccine contraindications. Anaphylaxis to a previous vaccine dose or any component of the vaccine is an absolute contraindication to further vaccination with that vaccine. See   section 16.6   for contraindications and precautions to DTaP ...

  • 15. Mumps

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/15-mumps

    ... whole blood transfusion does inhibit the response in up to 50 percent of vaccines recipients (see   section A6.4.1 ). MMR can safely be given to breastfeeding women. 15.6. Contraindications and precautions See also   section 2.1.3   for pre-vaccination screening guidelines and   section 2.1.4   for general vaccine contraindications. Expand all 15.6.1. Contraindications 15.6.1. Contraindications See   section 12.6.1   for specific MMR contraindications. Anaphylaxis to a previous dose of MMR or any of the vaccine components (includi ...

  • Health Information Standards Organisation (HISO)

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/digital-health/data-and-digital-standards/health-information-standards-organisation-hiso

    ... can be held legally responsible or liable by Health NZ for any act or omission of their own provided the member has acted responsibly as required by these terms of reference. Conflicts of interest Conflicts of interest Members shall comply with Health NZ’s conflicts of interest rules and guidelines. Members shall promptly declare to the chair any actual, potential or perceived conflict of interest in relation to a matter under consideration. The chair determines whether any conflicted member can continue to participate in discussions or voting on matters relating to the declared conflict ...

  • 8. Hepatitis A

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/8-hepatitis-a

    ... be any risk to the developing fetus and infant. As a precaution, HepA should be used during pregnancy only when clearly needed, such as when travelling to a country where HAV is endemic. 8.6. Contraindications and precautions See also   section 2.1.3   for pre-vaccination screening guidelines and   section 2.1.4   for general contraindications for all vaccines. Expand all 8.6.1. Contraindications 8.6.1. Contraindications Administration of HepA should be delayed in individuals suffering from acute febrile illness. HepA should not be administered to people with a history of ...

  • 5. Coronavirus disease (COVID-19)

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/5-coronavirus-disease-covid-19

    ... - 0.48 mL 0.48 mL - Dilution require (volume of NaCl to add) No No Yes (1.1 mL) Volume per dose 0.3 mL 0.3 mL 0.3 mL Doses per multidose vial - - 3 Primary course doses 1 1 3 a.  Only available for certain infants and children at increased risk of severe COVID-19 (see the   Starship guidelines for children with complex or multiple health conditions at increased risk of severe COVID-19 (external link) ). 5.4.5. Dosage and administration 5.4.5. Dosage and administration mRNA COVID‑19 vaccine – Comirnaty (Pfizer/BioNTech) JN.1 mRNA-CV (30 µg) for ages from 12 years  Each dose ...